Low interest rates and high stock valuations are fueling U.S. life sciences CEOs’ growing appetite for mergers and acquisitions, KPMG’s CEO Outlook found.
{iframe}https://home.kpmg/us/en/home/media/press-releases/2019/09/us-life-sciences-ceos-see-financial-drivers-as-catalyst-for-m-and-a-kpmg-poll.html{/iframe}